Amundi Purchases Shares of 15,623 Nu Skin Enterprises, Inc. (NYSE:NUS)

Amundi purchased a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS) during the 4th quarter, Holdings Channel.com reports. The fund purchased 15,623 shares of the company’s stock, valued at approximately $104,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of NUS. US Bancorp DE grew its holdings in shares of Nu Skin Enterprises by 424.2% in the 4th quarter. US Bancorp DE now owns 7,460 shares of the company’s stock worth $51,000 after purchasing an additional 6,037 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Nu Skin Enterprises by 2,412.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company’s stock worth $57,000 after purchasing an additional 7,888 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of Nu Skin Enterprises in the 3rd quarter worth about $93,000. Quarry LP grew its holdings in shares of Nu Skin Enterprises by 974.1% in the 3rd quarter. Quarry LP now owns 12,868 shares of the company’s stock worth $95,000 after purchasing an additional 11,670 shares during the last quarter. Finally, Proficio Capital Partners LLC bought a new stake in shares of Nu Skin Enterprises in the 4th quarter worth about $115,000. Institutional investors own 82.84% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th. DA Davidson lowered their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a report on Friday, December 20th.

Nu Skin Enterprises Stock Down 4.7 %

Shares of NYSE NUS opened at $7.74 on Friday. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. Nu Skin Enterprises, Inc. has a 12-month low of $5.95 and a 12-month high of $14.04. The company has a market cap of $384.61 million, a price-to-earnings ratio of -2.62 and a beta of 1.06. The firm’s 50-day simple moving average is $7.34 and its 200 day simple moving average is $7.11.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. On average, research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were given a $0.06 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.10%. Nu Skin Enterprises’s dividend payout ratio is -8.14%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.